Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy

Clinical trial NCT01329354 · UNKNOWN

Trial details

NCT number: NCT01329354
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Follicular Lymphoma Follicular Non-Hodgkin´s Lymphoma Autologous Effector Lymphocytes

Start date: 2011-03-01
Primary completion: 2019-11-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.